Intellectia.AI
Intellectia.AI is a technology company that builds AI-powered software tools designed for financial research and analysis. It operates strictly as a software provider and is not a broker, custodian, or investment adviser.
Claims from Intellectia.AI
Intellectia.AI"The firm notes the FDA accepted Intellia's BLA for lonvo-z in HAE and granted Priority Review, with a PDUFA date of March 10, 2027."Oct 01, 2026
Controversy:Will the FDA Approve Lonvo-Z by March 10, 2027?